May 6th 2024
In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Driving Patient Safety With New Pharmacy HIT Standards
August 11th 2023New standards from the National Council for Prescription Drug Programs could drive changes that improve patient safety by optimizing drug therapy to reduce the risk of harm and improve health and well-being before a medication is dispensed.
Read More
The Not So New Role of Pharmacists: No Longer an Overlooked Health Care Provider
July 31st 2023Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Read More
Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills
July 28th 2023Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.
Read More
Inflation Reduction Act, EOM, PBM Reform Remain Hot Topics on Capitol Hill
July 17th 2023Effective implementation of the Inflation Reduction Act may allow legislators to shift their focus toward controversial pharmacy benefit manager practices, according to a panel discussion during the ATOPP Summit.
Read More
What is 340B? Exploring Pharmacist Contributions, its Important Role in Hospitals
June 29th 2023The impact of pharmacist on reducing medication expenses cannot be overstated as they leverage their medication management expertise within hospital settings through collaboration with the 340B program.
Read More
CMS 2024 Final Rule Includes Surprises, Opportunities for Pharmacies and Payers
June 21st 2023Among health care professionals, pharmacists are best suited to serve as trusted partners for patients to help ensure they understand their medication regimen, identify medication-related problems, and work with prescribers to close gaps in care.
Read More
Have Children Truly Ever Been ‘Therapeutic Orphans?’
June 16th 2023Imposing the FDA on-label/off-label framework on administratively defined "children" resulted in a regulatory demand for pediatric studies that had no basis in clinical medicine, with the exception of the small group of preterm newborns.
Read More